Prostate Cancer E-Health-Tutorial
PROCET
1 other identifier
interventional
53
1 country
8
Brief Summary
In a participatory process involving urologists and former patients, the project team has developed an online information system ("tutorial") for patients with localized prostate cancer. In this field test, relevant outcomes are measured and the tutorial will be tested for its clinical applicability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable prostate-cancer
Started Jul 2015
Shorter than P25 for not_applicable prostate-cancer
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 16, 2015
CompletedFirst Posted
Study publicly available on registry
July 21, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2017
CompletedApril 24, 2017
April 1, 2017
1.6 years
July 16, 2015
April 21, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
information needs (own scale)
questionnaire developed in line with contents of the online tutorial
4 months
Secondary Outcomes (5)
Decision Quality: decisional conflict (Decisional Conflict Scale)
1 month
Decision Quality: decision regret (Decision Regret Scale)
4 months
Role in decision making: Preferred Role (Preferred Role in Decision Making Scale)
1 month
Role in decision making: Actual Role (Actual Role in Decision Making Scale)
4 months
Preparation for Decision Making (Preparation for Decision Making Scale)
1 month
Study Arms (1)
Intervention
EXPERIMENTALOnline Tutorial
Interventions
website informing about treatment options in localized prostate cancer
Eligibility Criteria
You may qualify if:
- tumor stage: clinical stage T1 or T2
- PSA level \<20 (PSA = Prostata-specific antigen)
- Gleason score \<8
- age ≤ 75 years
- Assumed life expectancy ≥ 10 years
- patients have to be diagnosed in one of the trial sites
- Internet-enabled device in the patient's household / basal user knowledge of this device
- signing of the consent form
You may not qualify if:
- Impaired judgment
- Insufficient ability to read and understand German
- Emotional problems
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
Urologische Universitätsklinik Basel, Kantonsspital Basselland
Liestal, Basel-Landschaft, 4410, Switzerland
UrologieZentrum Bern
Bern, Canton of Bern, 3000, Switzerland
Klinik für Urologie, Luzerner Kantonsspital
Lucerne, Canton of Lucerne, 6000, Switzerland
Urologisches Kompetenzzentrum soH
Olten, Canton of Solothurn, 4600, Switzerland
Klinik für Urologie, Kantonsspital St. Gallen
Sankt Gallen, Canton of St. Gallen, 9007, Switzerland
Klinik für Urologie, Stadtspital Triemli
Zurich, Canton of Zurich, 8036, Switzerland
Urologie, Kantonsspital Graubünden
Chur, Kanton Graubünden, 7000, Switzerland
Urologische Klinik, Kantonsspital Münsterlingen
Münsterlingen, Thurgau, 8596, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
René Schaffert, lic. phil.
Zurich University of Applied Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lic.phil.
Study Record Dates
First Submitted
July 16, 2015
First Posted
July 21, 2015
Study Start
July 1, 2015
Primary Completion
February 15, 2017
Study Completion
February 15, 2017
Last Updated
April 24, 2017
Record last verified: 2017-04